114,341 Shares in Establishment Labs Holdings Inc. (NASDAQ:ESTA) Acquired by Redmile Group LLC

Redmile Group LLC bought a new stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 114,341 shares of the company’s stock, valued at approximately $5,820,000. Redmile Group LLC owned approximately 0.42% of Establishment Labs at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the company. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Establishment Labs by 67.2% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,591 shares of the company’s stock worth $119,000 after purchasing an additional 1,845 shares during the last quarter. SG Americas Securities LLC bought a new stake in shares of Establishment Labs during the fourth quarter worth about $120,000. Concurrent Investment Advisors LLC purchased a new stake in shares of Establishment Labs in the first quarter worth approximately $263,000. Assenagon Asset Management S.A. raised its position in Establishment Labs by 357.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 30,247 shares of the company’s stock valued at $783,000 after buying an additional 23,639 shares during the last quarter. Finally, Stableford Capital II LLC purchased a new stake in shares of Establishment Labs in the first quarter valued at about $1,568,000. 72.91% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Establishment Labs news, CEO Quiros Juan Jose Chacon sold 3,641 shares of the stock in a transaction on Thursday, July 11th. The stock was sold at an average price of $45.04, for a total value of $163,990.64. Following the completion of the transaction, the chief executive officer now owns 210,735 shares in the company, valued at $9,491,504.40. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In the last quarter, insiders sold 14,346 shares of company stock valued at $647,806. Insiders own 11.44% of the company’s stock.

Establishment Labs Price Performance

Shares of Establishment Labs stock traded down $1.14 on Monday, hitting $47.06. 217,537 shares of the company traded hands, compared to its average volume of 372,539. The company has a market cap of $1.29 billion, a P/E ratio of -14.99 and a beta of 1.24. The company has a current ratio of 4.24, a quick ratio of 2.73 and a debt-to-equity ratio of 3.38. Establishment Labs Holdings Inc. has a 12-month low of $16.96 and a 12-month high of $73.00. The firm’s 50-day simple moving average is $47.23 and its 200 day simple moving average is $46.50.

Establishment Labs (NASDAQ:ESTA) last issued its quarterly earnings results on Wednesday, May 8th. The company reported ($0.58) EPS for the quarter, beating analysts’ consensus estimates of ($0.65) by $0.07. The business had revenue of $37.17 million for the quarter, compared to analysts’ expectations of $35.61 million. Establishment Labs had a negative net margin of 53.12% and a negative return on equity of 206.05%. During the same period last year, the business earned ($0.48) earnings per share. The business’s quarterly revenue was down 20.1% on a year-over-year basis. Analysts expect that Establishment Labs Holdings Inc. will post -1.79 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Citigroup dropped their price target on Establishment Labs from $60.00 to $50.00 and set a “neutral” rating on the stock in a report on Wednesday, July 10th. Mizuho increased their price target on shares of Establishment Labs from $65.00 to $70.00 and gave the stock a “buy” rating in a report on Thursday, June 6th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $54.00.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.